Genomic Precision

 A SeraCare blog focused on precision medicine and advanced clinical diagnostics

Vidya Murthy

Vidya is a Marketing Manager for In Vitro Diagnostics at SeraCare Life Sciences. Prior to joining SeraCare she was a Senior Scientist at Harvard Bioscience, where she led the product development as well as provided technical and marketing support for electroporation and electrofusion instruments. She holds a Ph.D. in Neuroscience from Tufts University School of Medicine. Her doctoral research was on regulation of gene and protein expression by nicotinic acetylcholine receptor and calcium activated K+ channel. Her post-doctoral research at Harvard Medical School was in Neurogenetics, studying the role of huntingtin protein in organogenesis and development using a variety of immunological assays.

Recent Posts

Improve the Reliability of Your Zika Diagnostic Assays

Robust molecular and serology reference materials for Zika diagnostic assays

Posted by Vidya Murthy on May 19, 2017 1:45:00 PM

What is Zika?

Zika virus (ZIKV) is an arbovirus that was first isolated in 1947 in a rhesus monkey from the Zika forest of Uganda. Until 2007, only 14 human cases were reported. The first large human outbreak occurred in 2007 (Yap Island, Micronesia, Pacific) followed by French Polynesia in 2013 that resulted in more than 30,000 cases. In early 2015, the virus came to international attention due to the outbreak in Brazil. Since then the epidemic has spread to more than 50 countries in the Caribbean, Central, and South America, causing tens of thousands of infections.


ZIKV is transmitted to people primarily through the bite of an infected Aedes species mosquito (Ae. aegypti and Ae. albopictus). These are the same mosquitoes that spread dengue and chikungunya. ZIKV can also be transmitted sexually and during pregnancy from the infected mother to the fetus.

Read More

Topics: Accuplex, zika virus, Blood screening, Women's health, pregnancy womens testing

 
 

Subscribe for Updates

Categories

see all